ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors

ARTBIO Germany Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/artbio-to-enter-into-licensing-and-research-partnership-with-3b-pharmaceuticals-to-advance-a-first-in-class-alpha-radioligand-therapy-for-solid-tumors-302303411.html